Triple
T2138581
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lucentis |
E46708
|
entity |
| Predicate | isRelatedDrug |
P24601
|
FINISHED |
| Object |
faricimab
Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
|
E238184
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88a174ab48190a5db20c132e5dccf |
elicitation | completed |
| NER | batch_69abc5af20808190902031d8c0bba376 |
ner | completed |
| NED1 | batch_69ae51b1290c8190a08850b428c99a6c |
ned_source_triple | completed |
| NED2 | batch_69ae55fdc32c8190b6ecdc9b23d64cc5 |
ned_description | completed |
| NEDg | batch_69ae55923b748190bf7a2df3ae94edc8 |
nedg | completed |
Created at: March 4, 2026, 7:44 p.m.